Scrip
FDA user fee date for Neuromed/Covidien's Exalgo pushed back to February
23 November 2009
Sue Sutter
Please Login to read the full article.
23 November 2009
Sue Sutter
The US FDA has extended the user fee date for Neuromed Pharmaceuticals' long-acting opioid Exalgo (hydromorphone extended-release tablets; licensed to Covidien) by three months to February 22nd, 2010.
On November 20th, the companies announced that they had recently provided the FDA with...
Please Login to read the full article.
RELATED CONTENT
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
